SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001654954-17-009281
Filing Date
2017-10-10
Accepted
2017-10-10 17:24:27
Documents
7
Period of Report
2017-08-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form6-k.htm 6-K 18693
2 EXHIBIT 99.1 ex991-mda.htm EX-99.1 617047
3 EXHIBIT 99.2 ex992-fs.htm EX-99.2 999619
4 EXHIBIT 99.3 ex993-pr.htm EX-99.3 344503
5 EXHIBIT 99.4 ex994-ceo.htm EX-99.4 13598
6 EXHIBIT 99.5 ex995-cfo.htm EX-99.5 13346
7 IMAGE intellipharmaceutics_logo.jpg GRAPHIC 7239
  Complete submission text file 0001654954-17-009281.txt   2018040
Mailing Address 30 WORCESTER ROAD TORONTO A6 M9W 5X2
Business Address 30 WORCESTER ROAD TORONTO A6 M9W 5X2 416-798-3001
Intellipharmaceutics International Inc. (Filer) CIK: 0001474835 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1130
Type: 6-K | Act: 34 | File No.: 000-53805 | Film No.: 171131243
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences